Best Life Sciences Companies in West Lafayette, United States
The 31 best Life Sciences companies in West Lafayette, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: On Target Laboratories.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in West Lafayette
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | On Target Laboratories Developer of molecular imaging agents for cancer surgery | $116M | 35 mo ago | Series C | 23 | Phil Low Founder & Chief Science Officer | WordPressApple iCloud MailMicrosoft 365+21 | 123 patents Targeted near‑infrared fluorescent dyes for cancer imaging and photodynamic therapy | — |
| 2 | Endocyte Innovative medicines company reimagining medicine to improve and extend people’s lives | $108M | 152 mo ago | Acquired | 220 | — | — | 639 patents Targeted cancer therapies: CAR‑T cell platforms and PSMA‑directed radiopharmaceuticals | — |
| 3 | Novosteo Developer of drug targeting technology for bone fracture repair | $27M | 54 mo ago | Acqui-Hired | 18 | — | — | — | — |
| 4 | eradivir Developer of immunotherapies for the treatment of infectious diseases 22Funding top 32%Talent top 38%Growth top 45%Moat bottom 38% All 7 signals ▾Fundingtop 32% Talenttop 38% Growthtop 45% Moatbottom 38% Globalbottom 29% Techbottom 24% Marketbottom 23% Funding: Raised $20.0M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $20M | 13 mo ago | Series A | 6 | Martin Low Co-Founder & CEO | WordPressMySQLPHP+11 | — | — |
| 5 | PURSPEC Manufacturer of high-end portable mass spectrometry instruments | $14M | 29 mo ago | Series A | — | Zheng Ouyang Founder | — | — | — |
| 6 | Amplified Sciences Developer of in-vitro diagnostic test for the detection of debilitating diseases across oncology and chronic… | $6M | 15 mo ago | Seed | 6 | Vincent Jo Davisson Founder and CSO | — | — | — |
| 7 | Adipo Therapeutics Developer of therapeutic solutions for the treatment of obesity & diabetes | $4M | 23 mo ago | Series A | 3 | Meng Deng Founder | WordPressMySQLPHP+15 | — | — |
| 8 | Animated Dynamics Advanced diagnostics using Motility Contrast Tomography for personalized cancer treatment | $3M | 97 mo ago | Series A | 3 | John Turek Co-Founder & VP | — | — | — |
| 9 | Rescue Biomedical Developer of a device to detect an opioid overdose | $3M | 48 mo ago | Funding Raised | — | Hyowon Lee CEO | — | — | — |
| 10 | Akina Research products and services for controlled release, medicinal delivery, biomedical applications | $3M | 38 mo ago | Funding Raised | 10 | — | — | 49 patents Biodegradable alkyl polyesters for medical drug delivery polymers | — |
| 11 | Perfinity Proteomics tools simplifying workflows for reproducible and accurate results | $2M | 196 mo ago | Seed | 4 | — | — | — | — |
| 12 | Akanocure Pharmaceuticals Developer of complex cancer therapies based on naturally occurring molecules | $2M | 70 mo ago | Funding Raised | 2 | — | — | — | — |
| 13 | Kylin Therapeutics Develops and delivers RNA interference based therapeutics | $2M | 204 mo ago | Deadpooled | — | J. Eric Davis President | — | — | — |
| 14 | BioVidria Develops products for protein analysis | $2M | 121 mo ago | Seed | 5 | — | — | — | — |
| 15 | Novilytic Developer of molecular recognition system to detect the quality of medicines | $2M | 11 mo ago | Seed | 8 | Paul Dreier Chief Executive Officer | — | 30 patents Proteoform-specific analytical validation and functional assessment for recombinant therapeutic proteins | — |
| 16 | APCI Provider of laboratory workflow scheduling and managing software for pharmaceutical industries | $1M | 171 mo ago | Funding Raised | 10 | — | — | 67 patents Linear friction welding systems and phase‑change metal joining technologies | — |
| 17 | Lyowave Developer of high-frequency microwave heating technology for pharmaceutical freeze-drying | $604K | 17 mo ago | Funding Raised | — | Dimitrios Peroulis Co-Founder | — | — | — |
| 18 | Microfluidic Innovations Neuroscience-based app for nervous system regulation, stress reduction, and mental clarity | $424K | 194 mo ago | Deadpooled | 6 | Mark Hobaugh Co-Founder & CEO | — | — | — |
| 19 | Bioscience Vaccines Vaccine adjuvant and companion products for infectious diseases and cancer. | $150K | 183 mo ago | Deadpooled | — | Paul Hall President and CEO | — | — | — |
| 20 | OmniVis Developer of a cholera pathogen detecting POC diagnostic device and app | $100K | 42 mo ago | Seed | 6 | Jacqueline Linnes Co-Founder | — | — | — |
| 21 | Medtric Antimicrobial nanotechnology solutions for healthcare, industrial, and agricultural applications | $60K | 143 mo ago | Seed | 4 | Sean Connell Co-Founder | — | — | — |
| 22 | Bridging Medical Group Bonebridging internal fixation devices | $35K | 110 mo ago | Series A | 3 | Robert Patty President - CEO | — | — | — |
| 23 | BASi Provider of drug discovery and development services and analytical instruments | — | 170 mo ago | Public | 1,955 | — | Cart FunctionalityZohoPHP+17 | — | — |
Top 12 Life Sciences companies in West Lafayette
#1
Series A · West Lafayette, Indiana · founded 2020 · 6 employees$20Mraised▾
Developer of immunotherapies for the treatment of infectious diseases. The company has developed a proprietary technology platform miniBIT to design targeted immunotherapies for multiple infectious diseases. The advanced product of the company's pipeline is a targeted therapy for influenza virus infections that eliminates all free virus and virus-infected cells.
- Oct 2025Series A$10M
- Sep 2024Grant (prize money)$1M
- Sep 2024Series A$10.2M
- Feb 2021Grant (prize money)$256K
#2
Seed · West Lafayette, Indiana · founded 2016 · 6 employees$5.6Mraised▾
Developer of in-vitro diagnostic test for the detection of debilitating diseases across oncology and chronic kidney disease. The company offers PanCystPro uses a proprietary platform to detect biomarker levels and activity in minute volumes of pancreatic cyst fluid for patients at higher risk for pancreatic cancer diagnosed with pancreatic cystic lesions.
- Aug 2025Seed$3M
- Mar 2025Grant (prize money)$454.9K
- Apr 2024Grant (prize money)$275K
- Mar 2024Grant (prize money)$274.8K
#3
Seed · West Lafayette, Indiana · founded 2021 · 8 employees$1.6Mraised▾
Developer of molecular recognition system to detect the quality of medicines. The company has developed a Proteometer that is capable of identifying and quantifying titer and relative aggregate content in crude culture filtrate. The Proteometer (Proteoform Meter) is a technology for drug development companies that provides near-real-time warnings on molecular structure changes.
- Dec 2025Seed$530.8K
- May 2022Seed$1.6M
- Jul 2021Grant (prize money)$1.4M
- Jun 2021Grant (prize money)$1.1M
#4
Series C · West Lafayette, Indiana · founded 2010 · 23 employees$116.5Mraised▾
Developer of molecular imaging agents for cancer surgery. It offers molecular imaging technology-based fluorescent markers to illuminate cancer during surgery so cancerous tissue can be removed during surgical procedures.
- Nov 2023Series C$30M
- Mar 2021Series B$21M
- Mar 2018Series B$11.1M
- Nov 2017Series B$32.5M
#5
Series A · West Lafayette, Indiana · founded 2016 · 3 employees$4Mraised▾
Developer of therapeutic solutions for the treatment of obesity & diabetes. The company has developed polymer-based, Notch-inhibiting nanoparticles that can be injected directly into adipose-like fat tissue to induce browning or white-to-beige adipocyte transformation. It helps in reducing weight and restoring metabolic balance for people living with diabetes. The therapeutic solution improves insulin sensitivity in the body and offers solutions like sustainable weight loss, improved glucose homeostasis, and systemic metabolism, with minimized off-target.
- Nov 2024Series A$4.7M
- Jan 2024Seed$1.9M
- Apr 2023Seed$242K
- Sep 2022Grant (prize money)$10K
#6
Funding Raised · West Lafayette, Indiana · founded 2016$604.4Kraised▾
Developer of high-frequency microwave heating technology for pharmaceutical freeze-drying. The technology accelerates the freeze-drying process, improving drying rate and uniformity. It is compatible with bench top to production scale freeze-drying systems. The technology facilitates transfer of freeze-drying processes from laboratory to commercial scales.
- May 2025Grant (prize money)$300K
- Feb 2025Grant (prize money)$304.4K
#7
Series A · West Lafayette, Indiana · founded 2015$13.8Mraised▾
Manufacturer of high-end portable mass spectrometry instruments. This company develops and produces mass spectrometry products for real-time, accurate, and simple detection in field testing and scientific research. They offer a variety of portable mass spectrometry instruments, including an ambient ionization ion source and an analyzer for structural lipidomics. The company's products are the result of extensive research and development collaborations with leading universities.
- May 2024Series A$13.8M
- May 2017Grant (prize money)$713K
#8
Acquired · West Lafayette, Indiana · founded 1996 · 220 employees$108Mraised▾
Innovative medicines company reimagining medicine to improve and extend people’s lives. The company focuses on developing and delivering innovative medicines to address significant disease burdens, empowering patients, healthcare professionals, and societies. It operates globally, offering a wide range of pharmaceutical products across various therapeutic areas, including cardiovascular, renal, metabolic, immunology, neuroscience, and oncology. The company is committed to research and development, exploring new technologies and collaborations to create transformative treatments. It emphasizes ethical behavior, environmental sustainability, and social responsibility, striving to make a positive impact on global health through access initiatives and patient support programs. The company engages with healthcare professionals, researchers, investors, and the public through various channels, providing resources, information, and opportunities for collaboration.
- Mar 2014Post IPO$95M
- Dec 2010Series C$8.1M
- Aug 2010Venture Debt$15M
- Oct 2009Series C$26.6M
#9
Acqui-Hired · West Lafayette, Indiana · founded 2017 · 18 employees$26.8Mraised▾
Developer of drug targeting technology for bone fracture repair. The company has designed a range of fracture-targeted drugs acting specifically at the fracture site. The pipeline drugs include NOV004 for fractures, spinal fusion, and osteogenesis imperfecta.
- Apr 2022Series B$17.7M
- Jan 2021Series A$8.4M
- Sep 2019Grant (prize money)$2M
- Aug 2019Seed$500K
#10
Funding Raised · West Lafayette, Indiana · founded 2001 · 10 employees$2.7Mraised▾
Research products and services for controlled release, medicinal delivery, biomedical applications. The company focuses on providing research reagents and products with a focus on biomedical applications. This includes biodegradable/biocompatible polymers, fluorescent products, chemical intermediates, and assay kits. It also offers services ranging from simple analysis to multi-year contracted research, leveraging experience with synthesis and characterization of novel polymer formulations. The company commercializes specialty and "hard-to-find" research supplies, including block copolymers, water-soluble polymers, fluorescent polymers, and reactive intermediates. It also distributes fluorescent dyes and chitosan. In addition to research products, the company performs contract research and custom synthesis.
- Sep 2023Grant (prize money)$320K
- Jul 2011Grant (prize money)$100K
- Aug 2009Grant (prize money)$750K
- Mar 2009Grant (prize money)$100K
#11
Funding Raised · West Lafayette, Indiana · founded 2019$3.2Mraised▾
Developer of a device to detect an opioid overdose. The company develops and researches proprietary technology to fight opioid overdose, It takes a life-saving naloxone delivery approach to reduce pain and reduce the usage of opioids, neurological damage, and healthcare burden for patients.
- Nov 2022Grant (prize money)$2.8M
- Sep 2022Grant (prize money)$375K
#12
Funding Raised · West Lafayette, Indiana · founded 2014 · 2 employees$2.3Mraised▾
Developer of complex cancer therapies based on naturally occurring molecules. The company's pipeline will consist of analogs of fully validated, highly potent anti-cancer natural products that can only be produced on a large scale through our proprietary Chiral Carbon Catalog (CCC) synthesis platform.
- Jan 2021Grant (prize money)$256K
- Apr 2020Grant (prize money)$750K
- Apr 2020Grant (prize money)$950K
- Jan 2018Grant (prize money)$225K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.